A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

The popularity of GLP-1 weight loss drugs has soared, which had created a shortage among many of the drugs, including Eli ...

A group representing companies that made copycat versions of Eli Lilly & Co.’s weight-loss drugs sued the US Food and Drug ...

Boehringer Ingelheim has received a breakthrough therapy designation from the US Food and Drug Administration (FDA) for ...

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

The plaintiffs allege that the shortage of Lilly’s drugs isn’t actually over, and that the agency’s decision deprives ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

America’s Eli Lilly is locked in a fight with Denmark’s Novo Nordisk to control the weight loss market. One product could ...